Hence then, the article about abbvie and gilgamesh pharmaceuticals announce collaboration and option to license agreement to develop next generation therapies for psychiatric disorders was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Therapies for Psychiatric Disorders )
Last updated :
Also on site :
- Ghirardelli Recalls 13 Popular Products Over Possible Contamination
- From Taylor Swift-Approved Jewelry to Made-to-Order Songs: The Most Unique Mother’s Day Gift Ideas for 2026
- Record Store Day NYC 2026 Report: Early Lines Across Brooklyn & Queens, Swift & Grateful Dead Top Sellers